Home Healthcare Pharmaceuticals Pneumonia Therapeutics Market

Pneumonia Therapeutics Market Size, Share & Trends Analysis Report By Product Type (Drugs, Vaccine, Oxygen Therapy), By Infection (Hospital-acquired Pneumonia (HAP), Community-acquired Pneumonia (CAP), Ventilator-associated Pneumonia (VAP)), By Route of Administration (Oral, Parenteral, Other Routes of Administration), By End Use (Hospitals, Homecare, Specialty Clinics, Other End Uses) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 06, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Pneumonia Therapeutics Market Size Analysis
    1. Introduction
    2. Pneumonia Therapeutics Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Drugs
      2. Vaccine
      3. Oxygen Therapy
    3. Pneumonia Therapeutics Market Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
      1. Hospital-acquired Pneumonia (HAP)
      2. Community-acquired Pneumonia (CAP)
      3. Ventilator-associated Pneumonia (VAP)
    4. Pneumonia Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Other Routes of Administration
    5. Pneumonia Therapeutics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Other End Uses
  7. North America Pneumonia Therapeutics Market Size Analysis
    1. Introduction
    2. Pneumonia Therapeutics Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Drugs
      2. Vaccine
      3. Oxygen Therapy
    3. Pneumonia Therapeutics Market Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
      1. Hospital-acquired Pneumonia (HAP)
      2. Community-acquired Pneumonia (CAP)
      3. Ventilator-associated Pneumonia (VAP)
    4. Pneumonia Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Other Routes of Administration
    5. Pneumonia Therapeutics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Other End Uses
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
  8. Europe Pneumonia Therapeutics Market Size Analysis
    1. Introduction
    2. Pneumonia Therapeutics Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Drugs
      2. Vaccine
      3. Oxygen Therapy
    3. Pneumonia Therapeutics Market Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
      1. Hospital-acquired Pneumonia (HAP)
      2. Community-acquired Pneumonia (CAP)
      3. Ventilator-associated Pneumonia (VAP)
    4. Pneumonia Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Other Routes of Administration
    5. Pneumonia Therapeutics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Other End Uses
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    8. France
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
  9. APAC Pneumonia Therapeutics Market Size Analysis
    1. Introduction
    2. Pneumonia Therapeutics Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Drugs
      2. Vaccine
      3. Oxygen Therapy
    3. Pneumonia Therapeutics Market Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
      1. Hospital-acquired Pneumonia (HAP)
      2. Community-acquired Pneumonia (CAP)
      3. Ventilator-associated Pneumonia (VAP)
    4. Pneumonia Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Other Routes of Administration
    5. Pneumonia Therapeutics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Other End Uses
    6. China
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    9. India
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
  10. Middle East and Africa Pneumonia Therapeutics Market Size Analysis
    1. Introduction
    2. Pneumonia Therapeutics Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Drugs
      2. Vaccine
      3. Oxygen Therapy
    3. Pneumonia Therapeutics Market Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
      1. Hospital-acquired Pneumonia (HAP)
      2. Community-acquired Pneumonia (CAP)
      3. Ventilator-associated Pneumonia (VAP)
    4. Pneumonia Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Other Routes of Administration
    5. Pneumonia Therapeutics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Other End Uses
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
  11. LATAM Pneumonia Therapeutics Market Size Analysis
    1. Introduction
    2. Pneumonia Therapeutics Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Drugs
      2. Vaccine
      3. Oxygen Therapy
    3. Pneumonia Therapeutics Market Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
      1. Hospital-acquired Pneumonia (HAP)
      2. Community-acquired Pneumonia (CAP)
      3. Ventilator-associated Pneumonia (VAP)
    4. Pneumonia Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Other Routes of Administration
    5. Pneumonia Therapeutics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Other End Uses
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Drugs
        2. Vaccine
        3. Oxygen Therapy
      3. Market Size & Forecast By Infection 2022-2034 (USD MILLION/ Units)
        1. Hospital-acquired Pneumonia (HAP)
        2. Community-acquired Pneumonia (CAP)
        3. Ventilator-associated Pneumonia (VAP)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Other Routes of Administration
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Other End Uses
  12. Competitive Landscape
    1. Pneumonia Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. AstraZeneca
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Eli Lilly and Company
    3. F. Hoffmann-La Roche Ltd.
    4. Mylan N.V.
    5. Teva Pharmaceutical Industries Ltd.
    6. Sanofi
    7. Novartis AG
    8. Sun Pharmaceutical Industries Ltd.
    9. Aurobindo Pharma
    10. BioVersys AG
    11. Lupin
    12. Pfizer Inc.
    13. Merck & Co., Inc.
    14. GlaxoSmithKline plc
    15. AbbVie Inc.
    16. Cipla Limited
    17. Innoviva Speciality Therapeutics
    18. Cumberland Pharmaceuticals
    19. Tabuk Pharmaceutical Manufacturing Company
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.